AMENDMENT TO LICENSE AGREEMENTLicense Agreement • November 7th, 2006 • SCOLR Pharma, Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledNovember 7th, 2006 Company IndustryThis Amendment to License Agreement (“Agreement”) made as of June 1, 2006 by and between SCOLR Pharma, Inc., a Delaware corporation formerly known as Nutraceutix, Inc. (hereafter referred to as “Company”), and Temple University – Of The Commonwealth System of Higher Education (hereinafter referred to as “Temple”).
AMENDED AND RESTATED EXCLUSIVE PATENT LICENSE AGREEMENT SCOLR PHARMA, INC. AND ARCHER-DANIELS-MIDLAND COMPANYExclusive Patent License Agreement • November 7th, 2006 • SCOLR Pharma, Inc. • In vitro & in vivo diagnostic substances • Illinois
Contract Type FiledNovember 7th, 2006 Company Industry JurisdictionTHIS AMENDED AND RESTATED EXCLUSIVE PATENT LICENSE AGREEMENT (“Agreement”) made as of August 10, 2006 by and between SCOLR Pharma, Inc., a Delaware corporation formerly known as Nutraceutix, Inc. (hereinafter referred to as “SCOLR”), and Archer-Daniels-Midland Company, a Delaware corporation (hereinafter referred to as “ADM”).
AMENDMENT TO LICENSE AGREEMENTLicense Agreement • November 7th, 2006 • SCOLR Pharma, Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledNovember 7th, 2006 Company IndustryThis Amendment to License Agreement (“Agreement”) effective as of August 10, 2006 by and between SCOLR Pharma, Inc., a Delaware corporation formerly known as Nutraceutix, Inc. (hereafter referred to as “Company”), and Temple University – Of The Commonwealth System of Higher Education (hereinafter referred to as “Temple”).
AMENDMENT NO. 1 TO DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • November 7th, 2006 • SCOLR Pharma, Inc. • In vitro & in vivo diagnostic substances
Contract Type FiledNovember 7th, 2006 Company IndustryTHIS AMENDMENT NO. 1 TO DEVELOPMENT AND LICENSE AGREEMENT (this “Amendment”), is made as of September 22, 2006 (the “Effective Date”), by and between SCOLR Pharma, Inc., a corporation organized and existing under the laws of the State of Delaware and having a place of business at 3625 132nd Avenue SE, Suite 400, Bellevue, Washington 98006 (“SCOLR”) and Wyeth Whitehall Pharmaceuticals, Inc. (as assignee of Wyeth, acting through its Wyeth Consumer Healthcare Division), a corporation organized and existing under the laws of the Commonwealth of Puerto Rico and having a place of business at Road No. 3, Kilometer 143.1, Guayama, Puerto Rico 00784 (together with its Affiliates, “Wyeth”).